Silencing cyclin-dependent kinase inhibitor 3 inhibits the migration of breast cancer cell lines

Abstract

Cyclin-dependent kinase inhibitor 3 (CDKN3) belongs to the dual-specificity protein phosphatase family, which is hypothesized to regulate cell cycle progression in tumor cells. However, whether CDKN3 is a potential therapeutic target for breast cancer remains to be elucidated. The present in vitro study aimed to investigate the potential roles of CDKN3 in… (More)
DOI: 10.3892/mmr.2016.5401

5 Figures and Tables

Topics

  • Presentations referencing similar topics